» » Results Show Experimental Drug to be Effective in Some Patients With Pancreatic or Ovarian Cancer

Results Show Experimental Drug to be Effective in Some Patients With Pancreatic or Ovarian Cancer

Results of the phase I clinical trial of the investigational agent DMOT4039A has found the drug to be well tolerated in some patients and display initial evidence of anti-cancer activity among patients suffering from pancreatic and ovarian cancers, researchers told the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO). The drug is in fact a combination of a chemotherapeutic agent with an antibody, technically called an antibody-drug conjugate ...

Read More
You have just read an article categorized health titled Results Show Experimental Drug to be Effective in Some Patients With Pancreatic or Ovarian Cancer.
Written by: editor - Saturday, May 31, 2014

There are currently no comments for "Results Show Experimental Drug to be Effective in Some Patients With Pancreatic or Ovarian Cancer"

Post a Comment

Subscribe to: Post Comments (Atom)